枫蓼肠胃康颗粒联合匹维溴铵片治疗腹泻型肠易激综合征临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R574.4

基金项目:


Clinical Study on Fengliao Changweikang Granules Combined with Pivecuronium Bromide Tablets for Diarrhea-Type Irritable Bowel Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察枫蓼肠胃康颗粒联合匹维溴铵片治疗腹泻型肠易激综合征(D-IBS) 脾胃湿热证的临 床疗效。方法:选取104 例D-IBS 脾胃湿热证患者,采用随机数字表法分为治疗组与对照组各52 例。对照组 给予匹维溴铵片治疗,治疗组在对照组基础上给予枫蓼肠胃康颗粒治疗,2 组均治疗8 周。比较2 组临床 疗效、不良反应发生率,以及治疗前后中医证候积分与血清炎症因子[肿瘤坏死因子-α(TNF-α)、白细胞介 素-6(IL-6)、白细胞介素-17(IL-17)] 水平。结果:治疗后,治疗组临床疗效总有效率98.08%,高于对照 组82.69% (P<0.05)。2 组腹痛、泻下不爽或急迫、胃脘胀闷、口臭口苦积分及总分均较治疗前降低(P< 0.05),治疗组上述4 项细则积分及总分均低于对照组(P<0.05)。2 组血清TNF-α、IL-6、IL-17 水平均较治 疗前降低(P<0.05),治疗组血清TNF-α、IL-6、IL-17 水平均低于对照组(P<0.05)。治疗期间,治疗组与 对照组不良反应发生率分别为5.77%、7.69%,2 组比较,差异无统计学意义(P>0.05)。结论:枫蓼肠胃康颗 粒联合匹维溴铵片治疗D-IBS 脾胃湿热证临床疗效显著,有利于缓解临床症状、减轻炎症反应,安全性好。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Fengliao Changweikang Granules combined with Pivecuronium Bromide Tablets for diarrhea- type irritable bowel syndrome (D- IBS) with spleen- stomach damp-heat syndrome. Methods:A total of 104 D-IBS patients with spleen-stomach damp-heat syndrome were divided into the treatment group and the control group by the random number table method, with 52 cases in each group. The control group was treated with Pivecuronium Bromide Tablets , and the treatment group was additionally treated with Fengliao Changweikang Granules based on the treatment of the control group. Both groups were treated for 8 weeks. The clinical effects, incidence of adverse reactions during the treatment,as well as the traditional Chinese medicine (TCM) syndrome scores and the levels of inflammatory factors in serum,including tumor necrosis factor- α (TNF-α),interleukin- 6 (IL-6) and interleukin- 17 (IL- 17) before and after treatment in the two groups were compared. Results: After treatment,the total clinical effective rate was 98.08% in the treatment group,higher than that of 82.69% in the control group (P<0.05). The scores of abdominal pain, ungratifying or urgent diarrhea, distension and distress of stomach duct,and fetid mouth odor and bitter taste in the mouth as well as the total scores in both groups were decreased when compared with those before treatment (P<0.05),and the above four scores as well as the total score in the treatment group were lower than those in the control group (P< 0.05). Compared with those before treatment,the levels of serum TNF-α,IL-6 and IL-17 in both groups were decreased (P<0.05),and the three levels above in the treatment group were lower than those in the control group (P<0.05). The incidence of adverse reactions in the two groups was 5.77% and 7.69% respectively,there being no significance in the difference (P>0.05). Conclusion:Fengliao Changweikang Granules combined with Pivecuronium Bromide Tablets has a significant clinical effect on D- IBS with spleen- stomach damp- heat syndrome, which can help mitigate the clinical symptoms and relieve the inflammatory responses,with good safety.

    参考文献
    相似文献
    引证文献
引用本文

柳燕.枫蓼肠胃康颗粒联合匹维溴铵片治疗腹泻型肠易激综合征临床研究[J].新中医,2023,55(4):59-62

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-02-24
  • 出版日期:
文章二维码